BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 20955218)

  • 1. Metabolomic analysis of human plasma from haemodialysis patients.
    Sato E; Kohno M; Yamamoto M; Fujisawa T; Fujiwara K; Tanaka N
    Eur J Clin Invest; 2011 Mar; 41(3):241-55. PubMed ID: 20955218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal function and serum albumin at the start of dialysis in 514 Chinese ESRD in-patients.
    Liu H; Peng Y; Liu F; Xiao H; Chen X; Huang A; Liu Y
    Ren Fail; 2008; 30(7):685-90. PubMed ID: 18704816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of gastrointestinal dialysis on the level of nitrogenous residues in the blood].
    Briker VA; Glezer GA
    Klin Med (Mosk); 1983 Nov; 61(11):126-33. PubMed ID: 6664046
    [No Abstract]   [Full Text] [Related]  

  • 4. Raised plasma total sialic acid levels are markers of cardiovascular disease in renal dialysis patients.
    Afzali B; Bakri RS; Bharma-Ariza P; Lumb PJ; Dalton N; Turner NC; Wierzbicki AS; Crook MA; Goldsmith DJ
    J Nephrol; 2003; 16(4):540-5. PubMed ID: 14696756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dynamics of serum myoinositol concentration changes during haemodialysis and peritoneal dialysis.
    Trznadel K; Walasek L; Waldemar L
    Acta Med Pol; 1977; 18(1):55-61. PubMed ID: 855681
    [No Abstract]   [Full Text] [Related]  

  • 6. Significance of serum creatinine values in new end-stage renal disease patients.
    Fink JC; Burdick RA; Kurth SJ; Blahut SA; Armistead NC; Turner MS; Shickle LM; Light PD
    Am J Kidney Dis; 1999 Oct; 34(4):694-701. PubMed ID: 10516351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis.
    Bain MA; Faull R; Fornasini G; Milne RW; Evans AM
    Nephrol Dial Transplant; 2006 May; 21(5):1300-4. PubMed ID: 16401621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Removal of uraemic retention solutes in standard bicarbonate haemodialysis and long-hour slow-flow bicarbonate haemodialysis.
    Basile C; Libutti P; Di Turo AL; Casino FG; Vernaglione L; Tundo S; Maselli P; De Nicolò EV; Ceci E; Teutonico A; Lomonte C
    Nephrol Dial Transplant; 2011 Apr; 26(4):1296-303. PubMed ID: 20813765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneal membrane characteristics in patients on peritoneal dialysis.
    Al-wakeel J; Al-Ghonaim M; Al-Suwaida A; Askar A; Usama S; Feraz N; Shah IH; Memon N; Qudsi A; Sulaimani F
    Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):49-53. PubMed ID: 21196612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac biomarkers and survival in haemodialysis patients.
    Sommerer C; Beimler J; Schwenger V; Heckele N; Katus HA; Giannitsis E; Zeier M
    Eur J Clin Invest; 2007 May; 37(5):350-6. PubMed ID: 17461980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of combined urea and creatinine clearance and prediction equations as measures of residual renal function when GFR is low.
    Almond A; Siddiqui S; Robertson S; Norrie J; Isles C
    QJM; 2008 Aug; 101(8):619-24. PubMed ID: 18540009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creatinine index and transthyretin as additive predictors of mortality in haemodialysis patients.
    Terrier N; Jaussent I; Dupuy AM; Morena M; Delcourt C; Chalabi L; Rouanet C; Canaud B; Cristol JP
    Nephrol Dial Transplant; 2008 Jan; 23(1):345-53. PubMed ID: 17890748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nail disorders in patients with chronic renal failure and undergoing haemodialysis treatment: a case-control study.
    Dyachenko P; Monselise A; Shustak A; Ziv M; Rozenman D
    J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):340-4. PubMed ID: 17309455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct determination of blood recirculation rate in hemodialysis by a conductivity method.
    Bosc JY; LeBlanc M; Garred LJ; Marc JM; Foret M; Babinet F; Tetta C; Canaud B
    ASAIO J; 1998; 44(1):68-73. PubMed ID: 9466504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B; Grujić-Adanja G
    Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overutilization of central venous catheters in incident hemodialysis patients: reasons and potential resolution strategies.
    Lenz O; Sadhu S; Fornoni A; Asif A
    Semin Dial; 2006; 19(6):543-50. PubMed ID: 17150058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in salivary composition in patients with renal failure.
    Tomás I; Marinho JS; Limeres J; Santos MJ; Araújo L; Diz P
    Arch Oral Biol; 2008 Jun; 53(6):528-32. PubMed ID: 18294611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease.
    Malyszko J; Bachorzewska-Gajewska H; Sitniewska E; Malyszko JS; Poniatowski B; Dobrzycki S
    Ren Fail; 2008; 30(6):625-8. PubMed ID: 18661413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of treatment frequency on haemodialysis dose: comparison of EKR and stdKt/V.
    Vartia A
    Nephrol Dial Transplant; 2009 Sep; 24(9):2797-803. PubMed ID: 19386748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidative stress in chronic renal failure patients treated by peritoneal dialysis.
    Al-Hashimi AF; Mohammed FH; Al-Khazragi AS
    Saudi Med J; 2004 Sep; 25(9):1186-92. PubMed ID: 15448763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.